recurrent bladder cancer

Showing 1 - 21 of 21

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Bladder Cancer, Recurrent Bladder Cancer, FGFR3 Gene Mutation Trial in United States (Erdafitinib)

Recruiting
  • Bladder Cancer
  • +2 more
  • Basking Ridge, New Jersey
  • +6 more
Aug 22, 2022

Recurrent Bladder Cancer Trial (FPA144)

No longer available
  • Recurrent Bladder Cancer
  • (no location specified)
Dec 9, 2021

Distal Urethral Cancer, Proximal Urethral Cancer, Recurrent Bladder Cancer Trial in United States (afatinib dimaleate,

Recruiting
  • Distal Urethral Cancer
  • +8 more
  • afatinib dimaleate
  • laboratory biomarker analysis
  • Atlanta, Georgia
  • +5 more
Sep 24, 2021

Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer Trial in

Completed
  • Distal Urethral Cancer
  • +10 more
  • Gemcitabine hydrochloride
  • +3 more
  • Springfield, Missouri
  • +1 more
Sep 17, 2020

Recurrent Bladder Cancer, Transitional Cell Carcinoma of the Bladder Trial in Cleveland (sunitinib malate, immunohistochemistry

Terminated
  • Recurrent Bladder Cancer
  • Transitional Cell Carcinoma of the Bladder
  • sunitinib malate
  • +4 more
  • Cleveland, Ohio
  • +1 more
Apr 17, 2019

Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Bladder Cancer, Recurrent Transitional Cell Cancer

Completed
  • Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter
  • +6 more
  • sorafenib tosylate
  • laboratory biomarker analysis
  • Toronto, Ontario, Canada
    Princess Margaret Hospital Phase 2 Consortium
Jul 26, 2018

Recurrent Bladder Cancer, Stage III Bladder Cancer, Stage IV Bladder Cancer Trial in Los Angeles (drug, other, genetic)

Terminated
  • Recurrent Bladder Cancer
  • +3 more
  • Los Angeles, California
    USC/Norris Comprehensive Cancer Center
May 10, 2018

Recurrent Bladder Cancer, Stage 0 Bladder Cancer, Stage I Bladder Cancer Trial in Buffalo (broccoli sprout extract, laboratory

Terminated
  • Recurrent Bladder Cancer
  • +4 more
  • broccoli sprout extract
  • +2 more
  • Buffalo, New York
    Roswell Park Cancer Institute
May 31, 2017

Bladder Cancer, Disease Progression, Recurrent Bladder Cancer Trial (Intravesical BCG instillation)

Completed
  • Bladder Cancer
  • +2 more
  • Intravesical BCG instillation
  • (no location specified)
May 31, 2017

Recurrent Bladder Cancer, Stage IV Bladder Cancer, Transitional Cell Carcinoma of the Bladder Trial in Belgium, France

Completed
  • Recurrent Bladder Cancer
  • +2 more
  • Trastuzumab
  • +3 more
  • Bruxelles, Belgium
  • +14 more
Feb 3, 2017

Recurrent Bladder Cancer, Stage 0 Bladder Cancer, Stage I Bladder Cancer Trial (robot-assisted laparoscopic surgery,

Withdrawn
  • Recurrent Bladder Cancer
  • +4 more
  • robot-assisted laparoscopic surgery
  • +2 more
  • (no location specified)
Nov 8, 2016

Adenocarcinoma of the Bladder, Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter Trial

Terminated
  • Adenocarcinoma of the Bladder
  • +12 more
  • sorafenib tosylate
  • laboratory biomarker analysis
  • Boston, Massachusetts
    Eastern Cooperative Oncology Group
May 20, 2014

Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Bladder Cancer, Recurrent Transitional Cell Cancer

Completed
  • Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter
  • +9 more
  • San Francisco, California
    UCSF-Mount Zion
Jun 4, 2013

Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer Trial in

Terminated
  • Distal Urethral Cancer
  • +8 more
  • trastuzumab
  • Chicago, Illinois
    Cancer and Leukemia Group B
May 1, 2013

Advanced Adult Primary Liver Cancer, Anaplastic Thyroid Cancer, Bone Metastases Trial in Columbus (recombinant interleukin-12,

Completed
  • Advanced Adult Primary Liver Cancer
  • +126 more
  • recombinant interleukin-12
  • ABI-007/carboplatin/trastuzumab
  • Columbus, Ohio
    Ohio State University Medical Center
Feb 27, 2013

Recurrent Bladder Cancer Trial in Houston (celecoxib, )

Completed
  • Recurrent Bladder Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Feb 12, 2013

Male Breast Cancer, Recurrent Bladder Cancer, Recurrent Breast Cancer Trial in Los Angeles (decitabine, pharmacological study,

Completed
  • Male Breast Cancer
  • +8 more
  • Los Angeles, California
    University of Southern California
Feb 6, 2013

Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer Trial in

Completed
  • Distal Urethral Cancer
  • +10 more
  • Boston, Massachusetts
    Eastern Cooperative Oncology Group
Jan 23, 2013

Recurrent Bladder Cancer, Stage I Bladder Cancer, Stage II Bladder Cancer Trial in Houston (Ad5CMV-p53 gene)

Completed
  • Recurrent Bladder Cancer
  • +5 more
  • Ad5CMV-p53 gene
  • Houston, Texas
    M D Anderson Cancer Center
Jan 22, 2013

Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma, Adult Anaplastic Oligodendroglioma Trial in Chicago (erlotinib HCl,

Completed
  • Adult Anaplastic Astrocytoma
  • +85 more
  • erlotinib hydrochloride
  • laboratory biomarker analysis
  • Chicago, Illinois
    Cancer and Leukemia Group B
Jan 15, 2013

Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Bladder Cancer, Recurrent Transitional Cell Cancer

Completed
  • Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter
  • +5 more
  • trastuzumab
  • +4 more
  • Ann Arbor, Michigan
    University of Michigan University Hospital
Jan 11, 2013